Login

Professional Master in Market Access of Health Products (MAHP)

Objectives

Market access is the knowledge to optimize the access of a healthcare product to the targeted population or end user. Market access is about packaging data in the right way, for the right customer at the right time. This program aim to:

  • Consider the implications the product may have on the wider healthcare market.
  • Understand the impact the changing healthcare market will have on health products.
  • Prepare a positive healthcare environment which supports uptake of health products.
  • Communicate the “value” of health product to the range of customers who influence uptake.

Rationale

  • Decision makers at the Reimbursement bodies are looking for professional members to talk same language (cost effectiveness, reimbursement schemes, health economics etc…)
  • Medical representatives are not qualified to accomplish this job due to lack of experience and supportive programs.
  • Pharmaceutical companies are looking for young and experienced individuals to approach the reimbursement bodies.

 

Objective

Pharmaceutical companies are building new departments that should deal with governmental and reimbursement bodies (public and private). This program will have great impact on educating/preparing new capabilities that are tailored for the Lebanese Market.

Market Access of Health Products program will be of great value to build new capabilities based on the following topics that could be communicated during this program:

  • Introduction and Importance of Health Economics
  • Health Economics Guidelines
  • Economic Evaluation of Health Programs
  • Market Access and Life Cycle Management
  • Structure of Reimbursement bodies
  • Healthcare Pricing and Reimbursement Processes
  • Key Account Management Strategies
  • Legislation and Regulatory Affairs
  • Negotiation skills
  • Communication skills and Body Language

Admission Conditions

Required Level:

For 2015/2016, the applicant could be a student who has finished his first year of Master (M1) in Biochemistry or Biology at the Faculty of Sciences. Application from other disciplines (Pharmacy, Medical, and Public Health) will be accepted as well. 

Students will be admitted on the basis of their academic ability together with personal face to face interview with the program admission committee.

Capacity:

There is a fixed maximum of 10 students that can be accepted to participate in the Market Access of Health Products Master’s program. 

Further Studies / Career Opportunities

This program will prepare highly qualified members from The Lebanese University to successfully handle gaps in current Lebanese market. Graduates will be able to be recruited in local and multi-national pharmaceutical companies as:

 

Phase 1:          - Key Account Specialists

                        - Market Access Specialists

 

Phase 2:          - Key Account Manager

                        - National Key Account Manager

 

Phase 3:          - Market Access Manager

Selected Teachers in Market Access of Health Products (MAHP)

Mazen Zakariya Kurdi

Full professor
Chemistry - Biochemistry department

Market Access of Health Products (MAHP) M2 Courses

    Semester 1

      Semester 2

      Eligibility

      • M1 Biochemistry
      • M1 Biology
      • Pharmacy
      • Doctor of Medicine
      • Laboratory Sciences

      General Infos

      • Diploma Level: BAC+5
      • Studies Duration:

        1 year

      • Type: Professional
      • Teaching Language: English
      • Total Credits Number: 60
      • Location: Rafic Hariri University campus - Hadath
      • Supervisor: Rita Jibrail Yazbeck Karam
      • Email: ritakmouawad(at)hotmail.com

      Selected Projects

      • Adherence to cardiovascular medication: A survey in patients with hypertension in Lebanon. (2014-2015)
      • The effect of a p300 activator on STAT3-induced gene expression. (2014-2015)
      • Impact of GSTM1 and GSTT1 mutations on the susceptibility to myocardial infarction in Lebanese population (2014-2015)
      • Effect of a p300 activator on LIF-induced STAT3 signaling in endothelial cells. (2014-2015)
      • Self-medication with drugs and food supplements: A survey in patients with hypertension in Lebanon (2014-2015)
      • Nitric Oxide and the inhibition of NF-kB “decrease/increase” endothelial cell proliferation: Relation with Gi protein levels. (2014-2015)
      • Effect of a p300 activator on STAT3 and Rel A levels in the nuclei of endothelial cells. (2014-2015)

      Selected Courses